Cannabis
Study finds first evidence of rare flavoalkaloids in cannabis leaves
Riportato dall'IA Immagine generata dall'IA Verificato
Researchers at Stellenbosch University say they have found the first evidence of rare phenolic compounds known as flavoalkaloids in cannabis leaves, after profiling dozens of plant chemicals across three commercially grown strains.
Curaleaf Holdings, Inc. conducted its first quarter 2026 earnings conference call on May 5, 2026. Company executives including CEO Boris Jordan and CFO Ed Kremer participated alongside analysts from major firms. The call included standard forward-looking statement disclaimers.
Riportato dall'IA
Il procuratore generale facente funzione degli Stati Uniti, Todd Blanche, ha firmato giovedì un ordine che riclassifica la marijuana terapeutica autorizzata dagli stati nella Tabella III, una categoria soggetta a regolamentazioni meno rigorose. Il provvedimento non legalizza la cannabis a livello federale, ma offre sgravi fiscali e riduce gli ostacoli alla ricerca. La decisione fa seguito a una direttiva del presidente Donald Trump volta ad accelerare il processo.
Laboratory research led by scientists at Khon Kaen University indicates that cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC), two key cannabis compounds, can slow the growth and spread of ovarian cancer cells in vitro, particularly when used together in a 1:1 ratio, while causing relatively limited damage to healthy cells. The early-stage findings, reported in Frontiers in Pharmacology, suggest a potential avenue for future ovarian cancer treatments but are far from clinical use.
Riportato dall'IA Verificato
Researchers at Washington State University report that rats with naturally higher baseline stress hormone levels are far more likely to self-administer cannabis vapor. In experiments described in Neuropsychopharmacology, resting stress hormones emerged as the strongest predictor of this drug-seeking behavior, suggesting potential early markers of vulnerability to problematic use.
A new study presented at the American College of Surgeons Clinical Congress found that nearly 42% of drivers killed in crashes in Ohio had active THC in their blood, with levels far exceeding legal limits. The prevalence remained unchanged even after recreational cannabis legalization in 2023. Researchers urge stronger public messaging on the risks of driving after marijuana use.
Riportato dall'IA
A cannabis-derived mouth spray has shown significant effectiveness in reducing chronic lower back pain, according to a new clinical study. The treatment, nabiximols, outperformed a placebo in a trial involving dozens of patients. Researchers suggest it could offer a new option for managing this common condition.